Q4 and Full-Year Revenue Growth
Q4 product revenue was $92.7M, up 4.5% sequentially and up 15.3% year-over-year. Full-year product revenue was $350.3M, up 12.1% YoY. Total product + royalty revenue including a $45M patent litigation settlement was $452.7M for FY2025, up 26.1% YoY from $359.1M.
Royalty and Licensing Momentum
Full-year royalty revenue was $57.4M, up 23.2% YoY (does not include the $45M one-time patent settlement). Management states IP licensing became a major contributor in 2025 and expects licensing to expand materially, referencing potential for 'hundreds of millions' in future licensing revenues and additional licensees.
Profitability Turnaround
Fiscal 2025 operating income was $81.8M (18.1% of revenue including the patent settlement) vs an operating loss of $1.3M in the prior year. Full-year net income rose to $118.6M from $6.1M, and fully diluted EPS increased to $2.61 from $0.14.
Improved Gross Margins Year-over-Year
Consolidated gross margin for FY2025 rose to 57.3%, up 6.1 percentage points from 51.2% in the prior year. Q4 gross margin was 55.4% (note: a 2.1 percentage point QoQ decline driven by a Q3 royalty catch-up).
Strong Balance Sheet and Cash Position
Cash and cash equivalents were $402.8M at quarter end. Q4 operating cash flow was ~$15.7M, accounts receivable net of reserves was $60.7M (DSOs 44 days), and inventories were $91.3M (up 1% sequentially). Q4 capex was $5.5M.
Improving Demand Metrics and Backlog
Book-to-bill improved (Q4 >1, management cited >1.2 in Q4 and continuing improvement into Q1), and 1-year backlog increased 15.8% sequentially to $176.9M, indicating strengthening bookings and demand visibility.
Segment Wins and Product Momentum
Advanced Products revenue for FY2025 increased 26% to $248.6M (from $197.3M), and the lead VPD customer is ramping Gen 4 production while planning a Gen 5 transition beginning in H2 2026—supporting a steep ramp through the end of 2026.
Capacity Planning and Large Market Opportunity
Management reports Fab 1 capacity is slightly above $1B annual product revenue (targeting ~80% utilization for optimal operation). They are planning a second fab/campus (up to 0.5M sq ft potential) and assessing alternate/partner sources to meet expected demand; estimated incremental fab capex range cited at ~$250–300M.